PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Podophyllotoxin is noted for its special effects in the treatment of these cancers [PMID:36438133].
Rhizomes and fruits mitigated symptoms in an ovariectomized rat model [PMID:40354838].
Rhizomes and fruits demonstrated therapeutic and anti-inflammatory effects in a rat model [PMID:41285229].
Ethanolic extract provided over 80% whole-body radioprotection in mice [PMID:15762843].
Evidence summary
PubMed sources
- 1.PMID: 36771657 (2023) — Light-Induced Flavonoid Biosynthesis in Sinopodophyllum hexandrum with High-Altitude Adaptation. · Plants (Basel, Switzerland)
- 2.PMID: 40354838 (2025) — Podophyllum hexandrum Royle mitigates perimenopausal symptoms in an OVX rat model by activating the PI3K/AKT/mTOR pathway and enhancing estrogen receptor expression. · Journal of ethnopharmacology
- 3.PMID: 36438133 (2022) — Phenolic profiles and antioxidant activity in different organs of Sinopodophyllum hexandrum. · Frontiers in plant science
- 4.PMID: 15762843 (2005) — Podophyllum hexandrum (Himalayan mayapple) extract provides radioprotection by modulating the expression of proteins associated with apoptosis. · Biotechnology and applied biochemistry
- 5.PMID: 33544520